Hong Kong's market regulator says the city is seeing a notable shift in the types of companies choosing to list on its stock exchange. Growth companies—particularly in biotech and artificial intelligence—now make up about 30% of new listings, up from just 10% in 2023. The comments came from Julia Leung, chief executive of the Securities and Futures Commission (SFC), during a seminar in Tokyo hosted by Japan's Financial Services Agency.
What's driving the change?
Leung said Hong Kong has adjusted its listing rules and market infrastructure to attract firms that may not be sustainably profitable yet but have significant growth ambitions. This is a deliberate strategy to compete for innovative companies that might otherwise look to list in other financial hubs.
One key part of the pitch is the city's clearing and settlement systems, which have been made smoother and more efficient. Hong Kong has also introduced listing regimes that allow companies to go public even before their products are fully commercialized, while still maintaining investor protections. These changes are designed to make the city more welcoming to businesses that need capital to fund research and development, especially in sectors like biotech and AI.
The shift is part of a broader trend in global markets, where exchanges are competing to attract the next generation of high-growth companies. For Hong Kong, this is a way to diversify its market beyond traditional industries like finance and property, and to position itself as a hub for innovation-driven businesses.
What does this mean for investors?
For everyday investors, the rise in growth company listings means more opportunities to invest in early-stage biotech and AI firms. However, it also comes with higher risk. These companies often have little or no revenue, and their share prices can be volatile as they work toward commercializing their products.
Investors should be aware that growth companies are different from established firms. They may not have a track record of profitability, and their success often depends on factors like regulatory approvals, clinical trial results, or technological breakthroughs. This is why the SFC's emphasis on investor protection is important—it aims to ensure that retail investors have access to adequate information and that the listing process is transparent.
The increase in growth listings also reflects a broader shift in the global economy, where innovation is becoming a key driver of growth. For investors, this means that Hong Kong's stock market is becoming more representative of the industries that are likely to shape the future, from healthcare to artificial intelligence.
Broader market context
Hong Kong's push to attract growth companies comes at a time when the city's stock market has been under pressure. The Hang Seng Index has faced headwinds from global economic uncertainty and geopolitical tensions. However, the recent strength in Chinese stocks following better-than-expected third-quarter growth could provide some support.
China's economy grew faster than forecast in the third quarter, which has eased pressure for large-scale stimulus and helped lift sentiment in the region. This could be positive for Hong Kong, as many of the companies listed there have significant exposure to the Chinese mainland. The yuan's rise to a four-year high is another sign of improving investor confidence in the region.
However, the biotech sector has been volatile recently. For example, a biotech ETF fell 2.6% after setbacks for some companies, highlighting the risks in this space. Investors considering new listings in biotech should be prepared for similar swings.
Looking ahead
The SFC's focus on growth companies is likely to continue, as Hong Kong seeks to maintain its status as a leading global financial center. The city is also working on improving its market infrastructure, including faster settlement times and better cross-border connectivity with mainland China.
For investors, the key takeaway is that Hong Kong is becoming a more diverse market, with a growing number of opportunities in high-growth sectors. But with those opportunities come risks, and it's important to do thorough research before investing in any company, especially those that are not yet profitable.
As the market evolves, keep an eye on how these new listings perform and whether the SFC's efforts to balance growth with investor protection are successful. The coming months will show whether this trend continues and whether it translates into long-term value for investors.
